Clinical trial
Prevention of Vascular Access Graft Failure in Patients With Chronic Renal…
NCT00086164 · Anesiva, Inc., Industry · Terminated
Key facts
| NCT number | NCT00086164 |
|---|---|
| Title | Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis |
| Official title | A Phase 1/2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Pilot Trial to Assess the Effect of Treatment of the Recipient Vein of a Polytetrafluoroethylene (PTFE) Vascular Access Graft With Two Concentrations of E2F Decoy as Compared to Placebo on Neointimal Hyperplasia and the… |
| Lead sponsor | Anesiva, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hyperplasia, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | edifoligide (E2F Decoy) |
| Start date | May 1, 2004 |
| First posted | Jun 29, 2004 |
| Last update posted | Jul 19, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: